Literature DB >> 22409964

Assessing the impact of diabetes-related comorbidities and care on the hospitalization costs for patients with diabetes mellitus in Japan.

Dulamsuren Lkhagva1, Kazuaki Kuwabara, Shinya Matsuda, Yan Gao, Akira Babazono.   

Abstract

OBJECTIVE: Because diabetes mellitus (DM) has been highlighted in several healthcare sectors, variations in the case mix of DM should be evaluated to promote effective disease management. Using a Japanese administrative database (2003), we investigated the impact of DM-related comorbidities and of their relevant care processes on healthcare costs incurred during hospitalization.
METHODS: Of 283,771 hospital admissions across 174 acute care hospitals, 27,853 patients with DM were analyzed. The following variables were analyzed according to age (<65 or ≥65 years), the presence of comorbidities, demographic characteristics, procedure-related complications, insulin use, surgical procedures (percutaneous minimally invasive intervention, hemodialysis, ventilation, and rehabilitation), length of stay (LOS), and total charge (TC; US$1=Y90). Multivariate analyses were applied to investigate the effects of DM-related complications and care processes associated with DM on TC.
RESULTS: The mortality and procedure-related complication rates were 2.1% and 2.7%, respectively. There were significant differences in the frequencies of comorbidities by age category. Among DM-related comorbidities, peripheral vascular disease had the greatest impact on increasing the LOS or TC. Minimally invasive procedures, hemodialysis, ventilation, and procedure-related complications were significant determinants of TC. Hemodialysis and invasive surgical procedures were independent predictors of procedure-related complications.
CONCLUSIONS: DM-related comorbidities and care process representative of the DM case mix were responsible for variations in healthcare costs during hospitalization.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22409964     DOI: 10.1016/j.jdiacomp.2011.12.004

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  6 in total

1.  Estimating the prevalence of comorbid conditions and their effect on health care costs in patients with diabetes mellitus in Switzerland.

Authors:  Carola A Huber; Peter Diem; Matthias Schwenkglenks; Roland Rapold; Oliver Reich
Journal:  Diabetes Metab Syndr Obes       Date:  2014-10-01       Impact factor: 3.168

Review 2.  Diabetes prevention in the real world: Insights from the JDPP and J-DOIT1.

Authors:  Naoki Sakane
Journal:  J Gen Fam Med       Date:  2017-10-09

3.  Prevalence and pattern of co morbidity among type2 diabetics attending urban primary healthcare centers at Bhubaneswar (India).

Authors:  Sandipana Pati; F G Schellevis
Journal:  PLoS One       Date:  2017-08-25       Impact factor: 3.240

4.  Adherence to dipeptidyl peptidase-4 inhibitor therapy among type 2 diabetes patients with employer-sponsored health insurance in Japan.

Authors:  Karen Kurtyka; Rie Nishikino; Chie Ito; Kim Brodovicz; Yong Chen; Kaan Tunceli
Journal:  J Diabetes Investig       Date:  2016-02-18       Impact factor: 4.232

5.  Diabetes as a risk factor of hospitalization in the surgical ward due to cancer in the elderly and middle-aged population.

Authors:  Mariusz Dąbrowski; Alina Grondecka
Journal:  Arch Med Sci       Date:  2016-03-22       Impact factor: 3.318

6.  Comparing the Economic Burden of Type 2 Diabetes Mellitus Patients with and without Medical Insurance: A Cross-Sectional Study in China.

Authors:  Chao Yang; Zhe Huang; Kexin Sun; Yonghua Hu; Xiaoyuan Bao
Journal:  Med Sci Monit       Date:  2018-05-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.